B.F. Ascher Halts Supplement/OTC Combo Sales Following FDA Warnings

B.F. Ascher has discontinued the sale of its Melagesic PM dietary supplement/OTC combination in response to FDA's decision the product is an unapproved new drug, according to the agency

More from Archive

More from Pink Sheet